Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,398 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Milan Score Predicts Objective Gastroesophageal Reflux Disease in Patients With Type 2 Esophagogastric Junction.
Ferrari D, Siboni S, Sozzi M, Visaggi P, Kristo I, Tolone S, Marabotto E, Bernardi D, Schoppmann SF, Rogers BD, Hobson A, Haworth J, Lee YY, Louie BE, Masuda T, Ivy ML, Milito P, Centorrino E, Theodorou D, Triantafyllou T, Pasta A, Calabrese F, Tee V, Cusmai L, Penagini R, Coletta M, Savarino E, Asti E, Gyawali CP, De Bortoli N. Ferrari D, et al. Among authors: masuda t. Neurogastroenterol Motil. 2025 Jan 6:e14987. doi: 10.1111/nmo.14987. Online ahead of print. Neurogastroenterol Motil. 2025. PMID: 39757994
Plasma amyloid beta biomarkers predict amyloid positivity and longitudinal clinical progression in mild cognitive impairment.
Ataka T, Kimura N, Kaneko N, Masuda T, Takeuchi Y, Yabuuchi K, Mizukami T, Takeuchi T, Ito T, Tasai H, Miyagawa T, Hanai S, Iwamoto S, Matsubara E. Ataka T, et al. Among authors: masuda t. Alzheimers Dement (N Y). 2024 Oct 10;10(4):e70008. doi: 10.1002/trc2.70008. eCollection 2024 Oct-Dec. Alzheimers Dement (N Y). 2024. PMID: 39748849 Free PMC article.
A Phase II, Open Label, Single-Arm Study on the Efficacy of Cabozantinib in Patients With Advanced/Metastatic Nonsmall Cell Lung Cancer Harboring MET Exon 14 Alterations who Developed Acquired Resistance to Tepotinib or Capmatinib (CAPTURE Trial).
Takeda M, Ota M, Iwama E, Sugawara S, Shukuya T, Umemura S, Tanaka H, Oki M, Takahama T, Masuda T, Nogami N, Shimokawa M. Takeda M, et al. Among authors: masuda t. Clin Lung Cancer. 2024 Dec 9:S1525-7304(24)00267-5. doi: 10.1016/j.cllc.2024.12.004. Online ahead of print. Clin Lung Cancer. 2024. PMID: 39743377
3,398 results